180 related articles for article (PubMed ID: 6389126)
1. A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
Calandra GB; Hesney M; Grad C
Eur J Clin Microbiol; 1984 Oct; 3(5):478-87. PubMed ID: 6389126
[TBL] [Abstract][Full Text] [Related]
2. Randomized, comparative trial of imipenem/cilastatin and moxalactam in the treatment of serious obstetric and gynecologic infections.
Berkeley AS; Freedman KS; Hirsch JC; Ledger WJ
Surg Gynecol Obstet; 1986 Mar; 162(3):204-8. PubMed ID: 3513346
[TBL] [Abstract][Full Text] [Related]
3. Imipenem/cilastatin: the first carbapenem antibiotic.
Lyon JA
Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
[TBL] [Abstract][Full Text] [Related]
4. Imipenem/cilastatin.
Barza M
Eur J Clin Microbiol; 1984 Oct; 3(5):453-5. PubMed ID: 6594233
[No Abstract] [Full Text] [Related]
5. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
Calandra GB; Hesney M; Brown KR
Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
[TBL] [Abstract][Full Text] [Related]
6. Imipenem versus moxalactam in the treatment of serious infections.
Eron LJ; Hixon DL; Park CH; Goldenberg RI; Poretz DM
Antimicrob Agents Chemother; 1983 Dec; 24(6):841-6. PubMed ID: 6581755
[TBL] [Abstract][Full Text] [Related]
7. Imipenem-cilastatin: the first thienamycin antibiotic.
Jacobs RF
Pediatr Infect Dis; 1986; 5(4):444-8. PubMed ID: 3523460
[No Abstract] [Full Text] [Related]
8. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.
Calandra GB; Ricci FM; Wang C; Brown KR
J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176
[TBL] [Abstract][Full Text] [Related]
9. Imipenem-cilastatin sodium (Primaxin).
Med Lett Drugs Ther; 1986 Mar; 28(709):29-31. PubMed ID: 3512968
[No Abstract] [Full Text] [Related]
10. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
Keller CA; Villavicencio J; Ramirez C
Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
[TBL] [Abstract][Full Text] [Related]
11. Imipenem: a new carbapenem antibiotic.
Lipman B; Neu HC
Med Clin North Am; 1988 May; 72(3):567-79. PubMed ID: 3280907
[TBL] [Abstract][Full Text] [Related]
12. Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers.
Standiford HC; Drusano GL; Bustamante CI; Rivera G; Forrest A; Tatem B; Leslie J; Moody M
Antimicrob Agents Chemother; 1986 Mar; 29(3):412-7. PubMed ID: 3459390
[TBL] [Abstract][Full Text] [Related]
13. [New antimicrobial agent series XXV: imipenem/cilastatin sodium].
Mashimo K
Jpn J Antibiot; 1987 Oct; 40(10):1713-23. PubMed ID: 3327961
[No Abstract] [Full Text] [Related]
14. Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.
Hackford AW; Tally FP; Reinhold RB; Barza M; Gorbach SL
Arch Surg; 1988 Mar; 123(3):322-6. PubMed ID: 3277587
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of imipenem/cilastatin sodium in gynecological infection].
Iwaki M; Sato H; Makinoda S; Demise M; Tabata M; Yamaguchi T; Takaoka H; Shinkai N; Okubo H; Sato H
Jpn J Antibiot; 1986 Jun; 39(6):1509-13. PubMed ID: 3463791
[TBL] [Abstract][Full Text] [Related]
16. Imipenem/cilastatin therapy for serious infections in neonates and infants.
Nalin DR; Jacobsen CA
Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
Garau J; Casagrán A; Sánchez C; Matas E
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
[TBL] [Abstract][Full Text] [Related]
18. Imipenem-cilastatin sodium.
Stene R
Iowa Med; 1986 Sep; 76(9):432-7. PubMed ID: 3771166
[No Abstract] [Full Text] [Related]
19. Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.
Lode H; Wiley R; Höffken G; Wagner J; Borner K
Antimicrob Agents Chemother; 1987 Oct; 31(10):1491-6. PubMed ID: 3324956
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of imipenem/cilastatin in the empirical treatment of septicemia.
Del Valle J; Noriega AR; Sanz F; Revilla AP; Otero JR
Scand J Infect Dis Suppl; 1987; 52():20-5. PubMed ID: 3331040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
